|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2.490 USD | +1.22% |
|
-8.79% | +52.76% |
| 07-08 | Ovid Therapeutics Names Kevin Norrett Chief Business Officer, Promotes CFO and Chief Strategy Officer | MT |
| 07-08 | Ovid Therapeutics Inc. Announces Executive Changes, Effective July 6, 2026 | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Bio Therapeutic Drugs
| Capi. | Sales Growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 459M | - | - | - | ||
| 54.49B | |||||
| 55.93B | |||||
| 23.87B | - | ||||
| 22.86B | - | ||||
| 20B |
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
